Click for best price
Biosimilar Testing Development Services Market Size, Share 2024
This research report provides a comprehensive analysis of the Biosimilar Testing and Development Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biosimilar Testing and Development Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biosimilar Testing and Development Services, challenges faced by the industry, and potential opportunities for market players.
The global Biosimilar Testing and Development Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biosimilar Testing and Development Services market presents opportunities for various stakeholders, including PK assay, Tiered Immunogenicity testing. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biosimilar Testing and Development Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biosimilar Testing and Development Services market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Key Features:
The research report on the Biosimilar Testing and Development Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biosimilar Testing and Development Services market.
Market Overview: The report provides a comprehensive overview of the Biosimilar Testing and Development Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Effector Binding, ELISA), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biosimilar Testing and Development Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biosimilar Testing and Development Services market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biosimilar Testing and Development Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biosimilar Testing and Development Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biosimilar Testing and Development Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biosimilar Testing and Development Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biosimilar Testing and Development Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biosimilar Testing and Development Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biosimilar Testing and Development Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market segment by Application
PK assay
Tiered Immunogenicity testing
NAb assays
Global Biosimilar Testing and Development Services Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilar Testing and Development Services, market overview.
Chapter 2: Global Biosimilar Testing and Development Services market size in revenue.
Chapter 3: Detailed analysis of Biosimilar Testing and Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar Testing and Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biosimilar Testing and Development Services Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Testing and Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Testing and Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Testing and Development Services Overall Market Size
2.1 Global Biosimilar Testing and Development Services Market Size: 2023 VS 2030
2.2 Global Biosimilar Testing and Development Services Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Testing and Development Services Players in Global Market
3.2 Top Global Biosimilar Testing and Development Services Companies Ranked by Revenue
3.3 Global Biosimilar Testing and Development Services Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Testing and Development Services Companies in Global Market, by Revenue in 2023
3.5 Global Companies Biosimilar Testing and Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Testing and Development Services Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Testing and Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Testing and Development Services Market Size Markets, 2023 & 2030
4.1.2 Effector Binding
4.1.3 ELISA
4.1.4 Kinetic Binding Assays
4.1.5 ADCC & CDC Cell-Based Assays
4.2 By Type - Global Biosimilar Testing and Development Services Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Testing and Development Services Revenue, 2019-2024
4.2.2 By Type - Global Biosimilar Testing and Development Services Revenue, 2025-2030
4.2.3 By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Testing and Development Services Market Size, 2023 & 2030
5.1.2 PK assay
5.1.3 Tiered Immunogenicity testing
5.1.4 NAb assays
5.2 By Application - Global Biosimilar Testing and Development Services Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Testing and Development Services Revenue, 2019-2024
5.2.2 By Application - Global Biosimilar Testing and Development Services Revenue, 2025-2030
5.2.3 By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Biosimilar Testing and Development Services Market Size, 2023 & 2030
6.2 By Region - Global Biosimilar Testing and Development Services Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Testing and Development Services Revenue, 2019-2024
6.2.2 By Region - Global Biosimilar Testing and Development Services Revenue, 2025-2030
6.2.3 By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Biosimilar Testing and Development Services Revenue, 2019-2030
6.3.2 US Biosimilar Testing and Development Services Market Size, 2019-2030
6.3.3 Canada Biosimilar Testing and Development Services Market Size, 2019-2030
6.3.4 Mexico Biosimilar Testing and Development Services Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Biosimilar Testing and Development Services Revenue, 2019-2030
6.4.2 Germany Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.3 France Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.4 U.K. Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.5 Italy Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.6 Russia Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.7 Nordic Countries Biosimilar Testing and Development Services Market Size, 2019-2030
6.4.8 Benelux Biosimilar Testing and Development Services Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Biosimilar Testing and Development Services Revenue, 2019-2030
6.5.2 China Biosimilar Testing and Development Services Market Size, 2019-2030
6.5.3 Japan Biosimilar Testing and Development Services Market Size, 2019-2030
6.5.4 South Korea Biosimilar Testing and Development Services Market Size, 2019-2030
6.5.5 Southeast Asia Biosimilar Testing and Development Services Market Size, 2019-2030
6.5.6 India Biosimilar Testing and Development Services Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Biosimilar Testing and Development Services Revenue, 2019-2030
6.6.2 Brazil Biosimilar Testing and Development Services Market Size, 2019-2030
6.6.3 Argentina Biosimilar Testing and Development Services Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, 2019-2030
6.7.2 Turkey Biosimilar Testing and Development Services Market Size, 2019-2030
6.7.3 Israel Biosimilar Testing and Development Services Market Size, 2019-2030
6.7.4 Saudi Arabia Biosimilar Testing and Development Services Market Size, 2019-2030
6.7.5 UAE Biosimilar Testing and Development Services Market Size, 2019-2030
7 Biosimilar Testing and Development Services Companies Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Company Summary
7.1.2 Eurofins Scientific Business Overview
7.1.3 Eurofins Scientific Biosimilar Testing and Development Services Major Product Offerings
7.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.1.5 Eurofins Scientific Key News & Latest Developments
7.2 SGS
7.2.1 SGS Company Summary
7.2.2 SGS Business Overview
7.2.3 SGS Biosimilar Testing and Development Services Major Product Offerings
7.2.4 SGS Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.2.5 SGS Key News & Latest Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Company Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Biosimilar Testing and Development Services Major Product Offerings
7.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.3.5 Charles River Laboratories Key News & Latest Developments
7.4 Pharmaceutical Product Development
7.4.1 Pharmaceutical Product Development Company Summary
7.4.2 Pharmaceutical Product Development Business Overview
7.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Major Product Offerings
7.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.4.5 Pharmaceutical Product Development Key News & Latest Developments
7.5 Exova
7.5.1 Exova Company Summary
7.5.2 Exova Business Overview
7.5.3 Exova Biosimilar Testing and Development Services Major Product Offerings
7.5.4 Exova Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.5.5 Exova Key News & Latest Developments
7.6 Source BioScience
7.6.1 Source BioScience Company Summary
7.6.2 Source BioScience Business Overview
7.6.3 Source BioScience Biosimilar Testing and Development Services Major Product Offerings
7.6.4 Source BioScience Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.6.5 Source BioScience Key News & Latest Developments
7.7 Intertek Group
7.7.1 Intertek Group Company Summary
7.7.2 Intertek Group Business Overview
7.7.3 Intertek Group Biosimilar Testing and Development Services Major Product Offerings
7.7.4 Intertek Group Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.7.5 Intertek Group Key News & Latest Developments
7.8 Medistri
7.8.1 Medistri Company Summary
7.8.2 Medistri Business Overview
7.8.3 Medistri Biosimilar Testing and Development Services Major Product Offerings
7.8.4 Medistri Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.8.5 Medistri Key News & Latest Developments
7.9 Pace Analytical Services
7.9.1 Pace Analytical Services Company Summary
7.9.2 Pace Analytical Services Business Overview
7.9.3 Pace Analytical Services Biosimilar Testing and Development Services Major Product Offerings
7.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.9.5 Pace Analytical Services Key News & Latest Developments
7.10 Sigma-Aldrich
7.10.1 Sigma-Aldrich Company Summary
7.10.2 Sigma-Aldrich Business Overview
7.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Major Product Offerings
7.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue in Global Market (2019-2024)
7.10.5 Sigma-Aldrich Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biosimilar Testing and Development Services Market Opportunities & Trends in Global Market
Table 2. Biosimilar Testing and Development Services Market Drivers in Global Market
Table 3. Biosimilar Testing and Development Services Market Restraints in Global Market
Table 4. Key Players of Biosimilar Testing and Development Services in Global Market
Table 5. Top Biosimilar Testing and Development Services Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Biosimilar Testing and Development Services Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Biosimilar Testing and Development Services Revenue Share by Companies, 2019-2024
Table 8. Global Companies Biosimilar Testing and Development Services Product Type
Table 9. List of Global Tier 1 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Biosimilar Testing and Development Services Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Biosimilar Testing and Development Services Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Biosimilar Testing and Development Services Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, (US$, Mn), 2025-2030
Table 30. Eurofins Scientific Company Summary
Table 31. Eurofins Scientific Biosimilar Testing and Development Services Product Offerings
Table 32. Eurofins Scientific Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 33. Eurofins Scientific Key News & Latest Developments
Table 34. SGS Company Summary
Table 35. SGS Biosimilar Testing and Development Services Product Offerings
Table 36. SGS Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 37. SGS Key News & Latest Developments
Table 38. Charles River Laboratories Company Summary
Table 39. Charles River Laboratories Biosimilar Testing and Development Services Product Offerings
Table 40. Charles River Laboratories Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 41. Charles River Laboratories Key News & Latest Developments
Table 42. Pharmaceutical Product Development Company Summary
Table 43. Pharmaceutical Product Development Biosimilar Testing and Development Services Product Offerings
Table 44. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 45. Pharmaceutical Product Development Key News & Latest Developments
Table 46. Exova Company Summary
Table 47. Exova Biosimilar Testing and Development Services Product Offerings
Table 48. Exova Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 49. Exova Key News & Latest Developments
Table 50. Source BioScience Company Summary
Table 51. Source BioScience Biosimilar Testing and Development Services Product Offerings
Table 52. Source BioScience Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 53. Source BioScience Key News & Latest Developments
Table 54. Intertek Group Company Summary
Table 55. Intertek Group Biosimilar Testing and Development Services Product Offerings
Table 56. Intertek Group Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 57. Intertek Group Key News & Latest Developments
Table 58. Medistri Company Summary
Table 59. Medistri Biosimilar Testing and Development Services Product Offerings
Table 60. Medistri Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 61. Medistri Key News & Latest Developments
Table 62. Pace Analytical Services Company Summary
Table 63. Pace Analytical Services Biosimilar Testing and Development Services Product Offerings
Table 64. Pace Analytical Services Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 65. Pace Analytical Services Key News & Latest Developments
Table 66. Sigma-Aldrich Company Summary
Table 67. Sigma-Aldrich Biosimilar Testing and Development Services Product Offerings
Table 68. Sigma-Aldrich Biosimilar Testing and Development Services Revenue (US$, Mn) & (2019-2024)
Table 69. Sigma-Aldrich Key News & Latest Developments
List of Figures
Figure 1. Biosimilar Testing and Development Services Segment by Type in 2023
Figure 2. Biosimilar Testing and Development Services Segment by Application in 2023
Figure 3. Global Biosimilar Testing and Development Services Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Biosimilar Testing and Development Services Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Biosimilar Testing and Development Services Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2023
Figure 8. By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 9. By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 10. By Type - Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 12. By Application - Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 14. By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 15. By Country - North America Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 16. US Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 20. Germany Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 21. France Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 28. China Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 32. India Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 34. Brazil Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue Market Share, 2019-2030
Figure 37. Turkey Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Biosimilar Testing and Development Services Revenue, (US$, Mn), 2019-2030
Figure 41. Eurofins Scientific Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. SGS Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Charles River Laboratories Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Exova Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Source BioScience Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Intertek Group Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Medistri Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Pace Analytical Services Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Sigma-Aldrich Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
